Dr Melissa Marie Ianitelli, DO | |
1030 Harrington St Ste 101, Mount Clemens, MI 48043-2967 | |
(586) 464-4010 | |
(586) 468-7997 |
Full Name | Dr Melissa Marie Ianitelli |
---|---|
Gender | Female |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 14 Years |
Location | 1030 Harrington St Ste 101, Mount Clemens, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497066963 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 5101018864 (Michigan) | Primary |
207R00000X | Internal Medicine | 5101018864 (Michigan) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Mclaren Macomb | Mount clemens, MI | Hospital |
Mclaren Oakland | Pontiac, MI | Hospital |
Henry Ford Macomb Hospital | Clinton township, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mclaren Oakland | 0547173213 | 49 |
Mclaren Medical Group | 3971416082 | 187 |
Mclaren Macomb | 8921912791 | 118 |
News Archive
On World Sleep Day, scientists are highlighting the number one reason that people are waking up at night – nocturia (otherwise known as the need to get up and urinate more than once during the night).
Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.
Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.
Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.
› Verified 2 days ago
Entity Name | Mclaren Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346396066 PECOS PAC ID: 3971416082 Enrollment ID: O20031106000025 |
News Archive
On World Sleep Day, scientists are highlighting the number one reason that people are waking up at night – nocturia (otherwise known as the need to get up and urinate more than once during the night).
Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.
Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.
Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.
› Verified 2 days ago
Entity Name | Mclaren Oakland |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053463778 PECOS PAC ID: 0547173213 Enrollment ID: O20031111000770 |
News Archive
On World Sleep Day, scientists are highlighting the number one reason that people are waking up at night – nocturia (otherwise known as the need to get up and urinate more than once during the night).
Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.
Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.
Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.
› Verified 2 days ago
Entity Name | Mclaren Macomb |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396014601 PECOS PAC ID: 8921912791 Enrollment ID: O20040120001000 |
News Archive
On World Sleep Day, scientists are highlighting the number one reason that people are waking up at night – nocturia (otherwise known as the need to get up and urinate more than once during the night).
Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.
Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.
Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Melissa Marie Ianitelli, DO 1030 Harrington St Ste 101, Mount Clemens, MI 48043-2967 Ph: (586) 464-4010 | Dr Melissa Marie Ianitelli, DO 1030 Harrington St Ste 101, Mount Clemens, MI 48043-2967 Ph: (586) 464-4010 |
News Archive
On World Sleep Day, scientists are highlighting the number one reason that people are waking up at night – nocturia (otherwise known as the need to get up and urinate more than once during the night).
Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.
Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.
Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.
› Verified 2 days ago
Akhlema Paru Haidar, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8142 Fax: 586-493-3250 | |
Dr. Vasudevarao Mandava, M.D Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 18 Market St, Suite C, Mount Clemens, MI 48043 Phone: 586-783-2222 Fax: 586-783-6280 | |
Robert A Chang, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 133 S Main St, Mount Clemens, MI 48043 Phone: 586-468-1600 Fax: 586-465-0329 | |
Jayne Olivia Mitchell, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000 | |
Misha Kaur Chowdhary, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3727 | |
Travis Singh Sekhon, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3727 | |
John Florian Kazmierski, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1030 Harrington St, Suite 101, Mount Clemens, MI 48043 Phone: 586-468-8500 Fax: 586-468-7997 |